In the News
Multitarget stool DNA tests not as cost-effective as FIT for early CRC detection
Fecal immunochemical tests (FITs) would still be more cost-effective than multitarget and next-generation stool DNA tests even if the other tests' costs were lowered to $100, a recent analysis found.
Combo flu, COVID-19 vaccine noninferior in adults ages 50 years and older, manufacturer trial finds
An mRNA vaccine candidate that combines flu and COVID-19 vaccinations elicited noninferior immune responses versus the standard flu and COVID-19 vaccines in a trial of patients ages 50 years and older, a study by Moderna found.
MKSAP Quiz: ED visit for progressive weakness
A 64-year-old man is evaluated in the emergency department for progressive weakness. He recently attended a national conference where three colleagues developed similar symptoms. Following a physical exam, lab and other studies, and imaging, what is the most likely diagnosis?
CDC releases updated recommendations on HIV postexposure prophylaxis
Among other guidance, the agency said nonoccupational postexposure prophylaxis is recommended within 72 hours of an exposure that presents a substantial risk for HIV transmission when the source has HIV without known sustained viral suppression.
Virtual board review, Internal Medicine Meeting recordings available from the College
ACP's Internal Medicine Board Review course can be livestreamed May 13 through 17, and ACP CME 165 is available for purchase.
Vote for your favorite entry
I.M. Matters Weekly from ACP's cartoon caption contest continues. Readers can vote for their favorite caption to determine the winner.